Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
3.10
Dollar change
-0.33
Percentage change
-9.62
%
Index- P/E- EPS (ttm)-15.60 Insider Own49.19% Shs Outstand10.34M Perf Week-14.13%
Market Cap32.05M Forward P/E- EPS next Y-0.59 Insider Trans0.08% Shs Float5.25M Perf Month-19.48%
Income-20.91M PEG- EPS next Q-0.34 Inst Own11.64% Short Float2.94% Perf Quarter-17.77%
Sales9.18M P/S3.49 EPS this Y39.41% Inst Trans81.65% Short Ratio4.41 Perf Half Y-42.91%
Book/sh-0.06 P/B- EPS next Y46.20% ROA-128.24% Short Interest0.15M Perf Year-44.14%
Cash/sh0.49 P/C6.29 EPS next 5Y- ROE-397.49% 52W Range2.31 - 6.75 Perf YTD-24.02%
Dividend Est.- P/FCF- EPS past 5Y-80.64% ROI-2118.14% 52W High-54.07% Beta1.62
Dividend TTM- Quick Ratio1.41 Sales past 5Y29.43% Gross Margin57.62% 52W Low34.27% ATR (14)0.35
Dividend Ex-Date- Current Ratio1.47 EPS Y/Y TTM-278.31% Oper. Margin-198.10% RSI (14)26.83 Volatility10.83% 8.84%
Employees85 Debt/Eq- Sales Y/Y TTM16.43% Profit Margin-227.81% Recom2.33 Target Price5.60
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q17.54% Payout- Rel Volume1.11 Prev Close3.43
Sales Surprise-15.91% EPS Surprise32.75% Sales Q/Q7.00% EarningsMar 28 AMC Avg Volume34.95K Price3.10
SMA20-15.92% SMA50-27.70% SMA200-22.27% Trades Volume38,687 Change-9.62%
Date Action Analyst Rating Change Price Target Change
Jan-12-22Resumed Cantor Fitzgerald Overweight $4
Mar-29-21Initiated Truist Buy $12
Jan-29-21Initiated Cantor Fitzgerald Overweight $10
Oct-30-20Initiated William Blair Outperform
Today 11:53AM
07:30AM
Mar-25-24 08:00AM
Mar-21-24 08:00AM
Mar-18-24 08:00AM
08:00AM Loading…
Mar-11-24 08:00AM
Feb-22-24 08:30AM
Feb-12-24 08:00AM
Feb-06-24 08:00AM
Jan-25-24 08:00AM
07:30AM
Dec-19-23 08:00AM
Dec-14-23 08:00AM
Dec-08-23 09:46AM
Dec-07-23 09:20AM
08:00AM Loading…
Dec-06-23 08:00AM
Nov-28-23 08:00AM
Nov-27-23 09:47AM
Nov-13-23 04:05PM
Nov-09-23 08:00AM
Oct-31-23 08:00AM
Oct-25-23 08:00AM
Oct-23-23 08:00AM
Oct-20-23 10:43AM
Sep-29-23 08:00AM
Sep-13-23 08:00AM
Sep-11-23 08:00AM
Aug-31-23 08:00AM
Aug-29-23 08:00AM
Aug-28-23 08:00AM
04:01PM Loading…
Aug-14-23 04:01PM
Aug-09-23 04:05PM
Jul-31-23 08:00AM
Jul-20-23 08:30AM
Jun-28-23 08:00AM
Jun-12-23 06:23PM
Jun-08-23 01:23PM
01:23PM
Jun-05-23 08:00AM
Jun-02-23 09:35AM
08:00AM
May-31-23 08:00AM
May-30-23 08:00AM
May-26-23 09:15AM
May-19-23 09:38AM
08:00AM
May-16-23 04:05PM
May-15-23 04:05PM
09:00AM
May-11-23 04:01PM
12:33PM
09:45AM
08:00AM
May-09-23 04:07PM
Apr-27-23 04:05PM
Mar-27-23 07:12AM
Mar-22-23 04:05PM
Mar-03-23 08:38AM
08:00AM
Jan-09-23 04:05PM
Jan-06-23 08:00AM
Dec-27-22 08:00AM
Nov-29-22 04:01PM
Nov-10-22 07:00AM
Nov-01-22 08:00AM
Oct-06-22 04:05PM
Oct-05-22 08:00AM
Sep-27-22 09:05AM
Sep-12-22 04:28PM
Aug-23-22 08:00AM
Aug-22-22 04:02PM
Aug-18-22 04:05PM
Aug-10-22 07:30AM
Aug-01-22 08:00AM
Jul-11-22 06:26AM
Jun-23-22 04:05PM
Jun-16-22 04:01PM
May-18-22 07:31AM
May-16-22 01:20PM
May-12-22 04:01PM
May-11-22 07:30AM
Apr-29-22 08:00AM
Apr-02-22 01:40PM
Mar-23-22 07:00AM
Mar-15-22 08:00AM
Feb-28-22 08:14AM
Feb-24-22 04:01PM
Feb-22-22 04:05PM
Feb-08-22 01:46PM
Feb-01-22 04:19AM
Jan-31-22 04:05PM
Jan-28-22 10:07AM
Jan-05-22 08:00AM
08:00AM
08:00AM
Dec-03-21 04:57AM
Nov-10-21 08:00AM
Nov-03-21 03:01PM
Nov-01-21 08:00AM
Oct-19-21 06:52AM
Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sandford NicolePresident & CEODec 06 '23Buy3.365,00016,80058,703Dec 06 05:21 PM
Merchant Minh HoangSecretary & General CounselDec 06 '23Sale3.379803,3030Dec 08 05:28 PM
Hombeck TorstenChief Financial OfficerSep 08 '23Buy4.302,2469,6583,000Sep 12 06:37 PM
SCHULER JACK W10% OwnerJul 24 '23Buy2.75181,800499,9501,883,656Jul 25 05:39 PM
Sandford NicolePresident & CEOJul 24 '23Buy3.9812,56350,001134,665Jul 25 05:16 PM
Herchuk Jannie PrestridgeDirectorJul 24 '23Buy3.988,79435,00023,833Jul 24 06:49 PM
Parnell WinfredDirectorJul 24 '23Buy3.986,28124,99831,513Jul 25 05:03 PM
Cavanaugh Stefanie L.DirectorJul 24 '23Buy3.986,28124,99834,904Jul 25 05:20 PM
Jordan Veronica GHDirectorJul 24 '23Buy3.983,76915,00134,575Jul 24 06:58 PM
Vos Ellen O'ConnorDirectorJul 24 '23Buy3.983,76915,00132,878Jul 26 04:28 PM
Merchant Minh HoangGeneral counsel and secretaryJul 24 '23Buy3.987543,0013,865Jul 25 04:58 PM
Fralick Celeste RachelleDirectorJul 24 '23Buy3.987543,00112,032Jul 26 07:28 PM
Hombeck TorstenChief Financial OfficerJul 24 '23Buy3.987543,001754Jul 24 06:53 PM
Phan Ryan ThinhCSO & COOJul 24 '23Buy3.986282,4993,939Jul 25 05:11 PM